Thu, June 30, 2022
Wed, June 29, 2022
Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022
Thu, June 23, 2022

Roy Buchanan Maintained (ABUS) at Buy with Decreased Target to $9 on, Jun 28th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-9-on-jun-28th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Roy Buchanan of JMP Securities, Maintained "Arbutus Biopharma Corporation" (ABUS) at Buy with Decreased Target from $10 to $9 on, Jun 28th, 2022.

Roy has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Roy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Roy


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $8.5 on, Monday, March 14th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $6 on, Friday, March 4th, 2022

Publication Contributing Sources